Atea Pharmaceuticals, Inc. (AVIR)
$4.98-0.99%Close
SELLBEAR · day 9
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $399M
- Beta
- 0.28
- P/E (TTM)
- -2.39
- Short % float
- 13.13%
- Days to cover
- 25.9
- SI change
- +3.4%
- 1W
- -1.78%
- 1M
- -6.39%
- vs SPY 1W
- -1.64%
- vs SPY 1M
- -8.90%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on AVIR?
- LOPJLB’s latest quantitative signal on Atea Pharmaceuticals, Inc. (AVIR) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is AVIR in?
- Atea Pharmaceuticals, Inc. (AVIR) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Atea Pharmaceuticals, Inc. (AVIR) do?
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections. Its lead product candidate is the regimen of bemnifosbuvir, a nucleotide NS5B inhibitor, and ruzasvir, an NS5A inhibitor, which is in Phase 3 clinical trial for the treatment of hepatitis C virus (HCV). The compan…